Metformin in gestational diabetes: the offspring follow up

Metformin in gestational diabetes: follow up of offspring of mothers treated with insulin compared with metformin

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ANZCTR

Registry ID

ACTRN12605000311651

Acronym

MiG:TOFU

Enrollment

300

Registered

2005-09-06

Start date

2004-12-01

Completion date

Unknown

Last updated

2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

When women with gestational diabetes were randomsied to insulin or metformin treatment in the MiG study, they were asked to consent to follow up of the offpsring. We are now doing the first follow up at 2 ears including detailed body composition measurements, physcial examination and neurodevelopmental assessment. We plan to continue longterm follow up to see if metformin exposure in utero modifies later risks of obesity and type 2 diabetes

Interventions

Offspring of women who have been randomised to metformin or insulin in the MiG study are being followed through childhood to assess growth and development.

Eligibility

Sex/Gender

All

Age

0 to No maximum

Healthy volunteers

Inclusion criteria

Offspring of women who were randomsied in the metformin in geststional diabetes study

Exclusion criteria

No exclusion criteria

Outcome results